Unique ID issued by UMIN | UMIN000003702 |
---|---|
Receipt number | R000004473 |
Scientific Title | Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption |
Date of disclosure of the study information | 2010/08/01 |
Last modified on | 2010/09/08 11:02:31 |
Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Drug - Food interaction of Oseltamivir(Tamiflu) in oral absorption
Japan |
Influenza
Infectious disease |
Others
YES
to confirm mechanism of oral absorption of Tamiflu in healthy male subjects
Pharmacokinetics
Exploratory
Pragmatic
Phase I
PK profiles of Oseltamivir and it's metabolite Ro64-0802 in plasma and urine
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Medicine |
The Tamiflu capsule is taken with water.
The Tamiflu capsule is taken with milk.
20 | years-old | <= |
45 | years-old | > |
Male
the investigators must ensure that all subjects being considered to meet the following inclusion criteria:
1) healthy male who is capable to understand and sign the informed consent.
2) male between 20 and <45 years of age on the day of signing informed consent
3)Body Mass Indes(BMI) between 17.6 and 26.4 kg/m2 inclusive
4)good health as determined by physical examination and laboratory tests etc.
the investigators must ensure that all subjects being considered to meet the following exclusion criteria or conditions:
1)history of allergy to Oseltamivir
2)difficult to take milk because of lactose intolerance etc.
3)disease thought to be decreased metabolic function of liver(acute hepatitis,chronic hepatitis,hepatic cirrhosis,liver carcinoma,jaundice)
4)decreased metabolic function of kidney
5)electrocardiogram (ECG) showing a QTc>460 msec
6)who take any drugs or supplement including St.John's wort within a week prior to test drug administration
7)fruit juice including grapefruit, orange or apple within 7 days prior to test drug administration
8)recent (past 3 months) participation in other clinical trial for investigational agent,the investigator determines this trial participation inadequate
9)donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation
10)any positive results of HBs-AG,HCV-AB,HIV AB,HIV AG,TPHA.
11)history of allergy to any medicines and foods
12)history of drug or alcohol abusement
13) the investigator determines inadequate
6
1st name | |
Middle name | |
Last name | Takuo Ogihara |
Takasaki University of Health and Welfare
Faculty of Pharmacy,Department of Pharmaceutical Science ,Biopharmaceutics laboratory
60 Nakaoorui-machi,Takasaki-shi,Gunma-ken
027-352-1180(ext.8311)
1st name | |
Middle name | |
Last name | Akihiro Inano |
Neues Corporation
Clinical research support
6-18,Tenya machi Hakata-ku,Fukuoka-City
092-283-7100
inano.akihiro@neues.co.jp
Takuo Ogihara
Takasaki University of Health and Welfare
Self funding
Japan
Medical corporation LTA Sumida Hospital
NO
医療法人 相生会 墨田病院(東京都)
2010 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2010 | Year | 05 | Month | 11 | Day |
2010 | Year | 08 | Month | 01 | Day |
2010 | Year | 09 | Month | 01 | Day |
2010 | Year | 09 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2010 | Year | 06 | Month | 03 | Day |
2010 | Year | 09 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004473